Cooper Profit Margin 2006-2018 | COO

Current and historical gross margin, operating margin and net profit margin for Cooper (COO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cooper net profit margin as of October 31, 2018 is 5.52%.
Cooper Annual Profit Margins
Cooper Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $11.941B $2.533B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.890B 21.37
McKesson (MCK) United States $24.410B 9.32
AmerisourceBergen (ABC) United States $17.870B 13.01
Align Technology (ALGN) United States $16.819B 42.91
Cardinal Health (CAH) United States $16.062B 10.78
Laboratory Of America Holdings (LH) United States $14.324B 12.96
Henry Schein (HSIC) United States $12.982B 21.34
DENTSPLY SIRONA (XRAY) United States $8.081B 16.14
West Pharmaceutical Services (WST) United States $7.854B 38.98
Merit Medical Systems (MMSI) United States $3.229B 38.23
Patterson (PDCO) United States $2.169B 16.57
CONMED (CNMD) United States $1.838B 30.53
STAAR Surgical (STAA) United States $1.496B 154.04
Atrion (ATRI) United States $1.445B 41.31
Antares Pharma (ATRS) United States $0.501B 0.00
Lifevantage (LFVN) United States $0.198B 28.14
Invacare (IVC) United States $0.161B 0.00
Endologix (ELGX) United States $0.073B 0.00
Pro-Dex (PDEX) United States $0.059B 26.53
Aceto (ACET) United States $0.045B 0.00
Biolase (BIOL) United States $0.023B 0.00